EFNA5 and medulloblastoma: Furthermore, since a constitutively active form of Smoothened mimics concentration-dependent actions of SHH [16], it would be of clinical interest to examine whether dual targeted inhibition of the SHH and ephrin-A5 impact medulloblastoma development.